Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Coccheri

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Minerva Cardioangiologica|February 18, 1999
[Venous color echo-doppler in diagnosis of proximal deep vein thrombosis: variability with different operators and comparison with phlebography]A De Fabritiis, G Palareti, C Legnani, et al.
Haematologica|January 1, 1992
Prophylaxis of venous thrombosis after gynaecological surgery: a controlled pilot study of defibrotideG Palareti, G Guazzaloca, C Legnani, et al.
Bullettino Delle Scienze Mediche|July 1, 1971
[Orthotopic transplantation of the liver in pigs. Preliminary results and further development of the research]A Faenza, L Masetti, S Biavati, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defectsC Legnani, G Palareti, F Grauso, et al.
Acta Haematologica|January 1, 1991
Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled studyC Finelli, G Palareti, M Poggi, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1989
Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trialF Balsano, S Coccheri, A Libretti, et al.
Thrombosis and Haemostasis|March 2, 1992
Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trialH Bounameaux, J D Banga, E Bluhmki, et al.
British Journal of Haematology|June 1, 1996
Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutationC Legnani, G Palareti, R Biagi, et al.
Stroke|May 1, 1997
Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) InvestigatorsC Morocutti, G Amabile, F Fattapposta, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2010
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD studyJ N Fiessinger, H Bounameaux, M A Cairols, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Minerva Cardioangiologica|February 18, 1999
[Venous color echo-doppler in diagnosis of proximal deep vein thrombosis: variability with different operators and comparison with phlebography]A De Fabritiis, G Palareti, C Legnani, et al.
Haematologica|January 1, 1992
Prophylaxis of venous thrombosis after gynaecological surgery: a controlled pilot study of defibrotideG Palareti, G Guazzaloca, C Legnani, et al.
Bullettino Delle Scienze Mediche|July 1, 1971
[Orthotopic transplantation of the liver in pigs. Preliminary results and further development of the research]A Faenza, L Masetti, S Biavati, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defectsC Legnani, G Palareti, F Grauso, et al.
Acta Haematologica|January 1, 1991
Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled studyC Finelli, G Palareti, M Poggi, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1989
Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trialF Balsano, S Coccheri, A Libretti, et al.
Thrombosis and Haemostasis|March 2, 1992
Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trialH Bounameaux, J D Banga, E Bluhmki, et al.
British Journal of Haematology|June 1, 1996
Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutationC Legnani, G Palareti, R Biagi, et al.
Stroke|May 1, 1997
Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) InvestigatorsC Morocutti, G Amabile, F Fattapposta, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2010
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD studyJ N Fiessinger, H Bounameaux, M A Cairols, et al.
Pageof 12